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-7/del(7q) in childhood blood malignancies exhibits a 
specific pattern of pathogenesis; chromosome 7 
anomalies are not rare in acute lymphocytic leukaemi  
(ALL); they occur in balanced translocations involving 
7p15 or 7q34 in T lineage and 7q22 or 7q32 in B 
proliferations; monosomy 7 is present in 5 to 6 % of 
ALL, most often as a secondary anomaly of the t(9;22); 
the association t(9;22), -7 is present in 16 % of the
Ph1+ ALL, i.e. in 3% of ALL as a whole; we will 
hereunder focuse on -7/del(7q) in adult 
myeloproliferations. 
 
del(7q) G- banding - Courtesy Jean-Luc Lai and Alain 
Vanderhaegen. 
Clinics and pathology 
Disease 
Myelodysplastic syndromes (MDS) and acute non 
lymphocytic leukemia (ANLL); they may occur de 
novo, or be secondary to an exposure to chemical 
mutagens or to chemotherapy treatments with 
alkylating agents; may probably also be secondary to 
immunosuppressive therapy for severe aplastic anemia. 
Phenotype/cell stem origin 
MDS cases : found in 30% of RAEB/RAEB-T, 20% of 
CMML, and only 5% of RA with an abnormal 
karyotype;  
ANLL most often M4 or M6 ; 
Monosomy 7 and these deletions does not seem a 
specific feature of the dysplastic clone in the MDS, 
they are secondary events contributing to the 
leucogenesis. 
Epidemiology 
-7 is the most frequent abnormality in secondary 
myeloid disorders, found in 51% of the cases in a serie  
of 246 cases, while del(7q) was found in 7%, and a 
partial monosomy 7 as a result of an unbalanced 
translocation in 8% of cases; in contrast, -7/del(7q) is 
found in 10% of de novo myeloid disorders; the sex 
ratio is 1.5 male for 1 female; the proportion of adults 
with a -7 myeloid disorder grows dramatically after 60 
years. 
Clinics 
Characterized by infectious susceptibility, quick 
aggravation, and treatment resistance. 
Prognosis 
Monosomy 7 is classified as a poor prognostic 
criterium by the International Prognostic Scoring 
System; the actuarial relapse rate at one year is 82 %, 
and the 7-yr actuarial event-free survival is 6 %; after 
an allogeneic bone marrow transplantation, -7 is 
predictive of an unfavorable outcome. 
Cytogenetics 
Cytogenetics morphological 
Deletion (7q) is always interstitial; cluster of 
breakpoints in 7q11 to 7q36, is a with two common 
minimal zones in q22 and in q32-34. 
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Using loss of heterogygocity (LOH) studies and YAC 
libraries, a 2 to 3 Mb segment in 7q22 has been 
designated as the proximal common deleted area; the 
7q33-34 zone is the consensual area for the distal 
deletion; LOH studies suggest that a specific 
mechanism, such as mitotic recombination in bone 
marrow stem cell leading to homozygosity in both 
granulocytes and lymphocytes, may be implicated. 
Probes 
Chromosomal band 7q221: marker D7S658, through 
D7S2494, YAC HSC7E441 to HSC7E572; 7q33-34: 
D7S498 to D7S505; near-centromeric probes of 
chromosome 7 and 7q31 probes are produced by 
commercial companies. 
Additional anomalies 
-5/del(5q), found in 40 to 60 % of the secondary MDS 
cases; trisomy 8. 
Variants 
The balanced translocation t(1;7)(q10;p10), and many 
unbalanced translocation, having for consequence a 
partial monosomy 7 of the 7q22 to 7q34 bands may, in 
a way, be considered as variants. 
Genes involved and proteins 
Note 
-7/del(7q) is not only frequent in secondary MDS or 
ANLL, but also in leukemias occurring in individuals 
with constitutional syndromes including predispositi n 
to myeloid disorders; these findings suggest the 
presence of a putative myeloid leukemia suppressor 
gene in the commonly deleted genomic segment 7q22 
and even multiple genes in 7q22 -31.1 that are playing 
a role in leukemogenesis;  
candidate genes are :  
ASNS (asparagine synthetase gene) in 7q21.3-q22.1; 
ACHE (acetyl cholinesterase), EPO (erythropoietin), 
PLANH1 (plasminogen activator inhibitor 1) in 7q22; 
and MET in 7q31.2-31.3. 
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